Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds

NCT01655407 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Thermal Injury
Deep Partial-Thickness Burn
Full-Thickness Burn

Interventions

DRUG: Autologous Engineered Skin Substitute
DRUG: Split-Thickness Autograft (AG)

Sponsor

Amarantus BioScience Holdings, Inc.

Collaborators

[object Object]